Dr. Sunisha Arora: Consultant at Fortis memorial research institute, India
Dr. Sunisha Arora is a dedicated Pediatric Hematologist & Oncologist with specialized expertise in Bone Marrow Transplantation, Pediatric Oncology, and General Pediatrics. She brings a compassionate approach to managing complex hematological malignancies and critical pediatric cases. Based in Gurugram, India, Dr. Arora combines clinical excellence with active research and teaching roles. She is recognized for her strong commitment to improving pediatric cancer care and outcomes.
Online Profiles
Dr. Sunisha Arora is affiliated with Medanta – The Medicity, Gurugram, India, and holds a Scopus ID: 57225205301. Her research contributions include 13 published documents cited 25 times across 24 different works, reflecting a growing influence in pediatric hematology and oncology. She has an h-index of 3, indicating her work’s recognition and impact within the academic community. Dr. Arora is encouraged to connect her research profile with ORCID to further enhance visibility and collaboration opportunities.
Education
She earned her Fellowship of National Board (FNB) in Pediatric Hematology & Oncology from Medanta, The Medicity, Gurugram (2021–2023), where she gained specialized training in bone marrow transplantation and pediatric cancer care. She completed her MD Pediatrics at GSVM Medical College, Kanpur (2015–2018), and her MBBS from MVJ Medical College & Research Hospital, Bangalore (2008–2013). Dr. Arora’s academic foundation was built on consistently high performance during school years at Kendriya Vidyalayas in Bangalore and Assam.
Research Focus
Dr. Arora’s research interests include pediatric infections in oncology patients, management of COVID-19 in immunocompromised children, graft-versus-host disease (GVHD), and outcomes of stem cell transplantation in children. She is committed to advancing knowledge on complications following transplantation and improving patient survival and quality of life through evidence-based interventions.
Experience
Currently, Dr. Arora works as an Associate Consultant in Hematology & Bone Marrow Transplantation at Fortis Memorial Research Institute, Gurugram. She has previously held similar consultant roles at Max Super Specialty Hospital, Patparganj, and was a Senior Resident and Fellow in Pediatric Hematology/Oncology and BMT at Medanta. Her clinical experience spans across critical care, general pediatrics, and specialized pediatric oncology services, managing both routine and complex cases.
Research Timeline & Activities
Dr. Arora initiated her research career with a prospective study on Central Venous Pressure measurement in sick neonates (2015–2017), contributing valuable clinical data for neonatal management. Over the years, she has conducted outcome audits on acute lymphoblastic leukemia (ALL), neuroblastoma, and hematopoietic stem cell transplantation (HSCT)-related graft-versus-host disease. Her active participation in international and national conferences underscores her commitment to ongoing professional development and knowledge dissemination.
Awards & Honors
Dr. Arora’s work has been recognized with multiple awards, including 1st Prize at UP Pedicon 2016 for her study on Vitamin D supplementation and Best Poster Presentation at PHOCON Jammu. She has also received commendations for her oral and poster presentations at conferences such as SIOP, EBMT, and PHO Conferences, reflecting her strong research and clinical contributions.
Top Noted Publication
One of Dr. Arora’s notable publications is featured in the Pediatric Hematology Oncology Journal, focusing on graft-versus-host disease management and transplantation outcomes in pediatric patients. This publication has contributed important insights into improving post-transplant care protocols and minimizing complications, benefiting clinicians and researchers in pediatric hematology-oncology worldwide.
One of Dr. Sunisha Arora’s recent significant publications is an open-access article titled “Treatment of Pediatric Acute Lymphoblastic Leukemia in India as per modified BFM 95 protocol with Minimal Residual Disease monitoring,” published in Hematology (United Kingdom) in 2025. This study addresses tailored treatment approaches for pediatric acute lymphoblastic leukemia (ALL) in the Indian context, emphasizing the role of Minimal Residual Disease (MRD) monitoring to improve treatment outcomes.
Strengths for Best Innovator Award
Innovative Pediatric Oncology Treatment Protocols
Dr. Arora has contributed to the adaptation and implementation of the modified BFM 95 protocol with Minimal Residual Disease (MRD) monitoring for pediatric acute lymphoblastic leukemia in India. This innovation in treatment tailoring enhances precision and improves outcomes for children in resource-constrained settings.Pioneering Research in Stem Cell Transplantation & GVHD
Her focused research on graft-versus-host disease (GVHD) management and transplantation outcomes has led to improved post-transplant care protocols. These innovations help minimize complications and enhance survival rates in pediatric hematology-oncology patients.Integration of Research with Clinical Practice
Dr. Arora effectively bridges clinical expertise with active research, applying evidence-based interventions in real-world settings. Her prospective studies and outcome audits directly inform and improve patient care strategies, exemplifying translational innovation.Leadership in Multidisciplinary Pediatric Care
Her roles across top institutes and multidisciplinary teams, including critical care and bone marrow transplantation, demonstrate innovative leadership in complex pediatric cases, ensuring comprehensive and personalized care approaches.Active Knowledge Dissemination & Capacity Building
Through frequent presentations at national and international conferences and engagement in workshops, Dr. Arora actively promotes knowledge sharing and professional development in pediatric hematology-oncology, fostering innovation in the wider medical community.